Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2009 | Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity. | Juan, TY; Roffler, SR; Hou, HS; Huang, SM; Chen, KC; Leu, YL; Prijovich, ZM; Yu, CP; Wu, CC; Sun, GH; Cha, TL | CLINICAL CANCER RESEARCH 15(14), 4600-4611 | | | |
2015 | Novel Cancer Therapeutics with Allosteric modulation of the mitochondrial c-Raf-DAPK complex by Raf inhibitor combination therapy. | Tsai, YT; Chuang, MJ; Tang, SH; Wu, ST; Chen, YC; Sun, GH; Hsiao, PW; Huang, SM; Lee, HJ; Yu, CP; Ho, JY; Lin, HK; Chen, MR; Lin, CC; Chang, SY; Lin, VC; Yu, DS; Cha, TL | Cancer Research 75(17), 3568-3582 | | | |
2014 | Pharmacologic Down-regulation of EZH2 Suppresses Bladder Cancer in vitro and in vivo | Tang, SH; Huang, HS; Wu, HU; Tsai, YT; Chuang, MJ; Yu, CP; Huang, SM; Sun, GH; Chang, SY; Hsiao, PW; Yu, DS; Cha, TL | Oncotarget 5(21), 10342-10355 | | | |